Just attended the presentation. Impressive technology.
key benefits
1: Impressive In Vivo results in mice
2: good survival rates over 90 days
3: the protection from reoccurrence without additional dosage 4: the off shelf treatment from healthy donors ( big advantage compared to using the cells taken from the patients which is faster, cheaper and potential of healthier cells being used instead of compromised cells from the affected patients).
5: patents to 2038
6: develop additional products using other CAR cells.
- Forums
- ASX - By Stock
- Ann: SUDA Licenses a Novel iNKT Cell Therapy Platform
Just attended the presentation. Impressive technology.key...
Featured News
Add ALA (ASX) to my watchlist
|
|||||
Last
14.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $147.2M |
Open | High | Low | Value | Volume |
14.0¢ | 14.3¢ | 14.0¢ | $27.89K | 199.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 600459 | 14.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
14.5¢ | 114841 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 600459 | 0.140 |
16 | 506429 | 0.135 |
10 | 776315 | 0.130 |
9 | 451775 | 0.125 |
10 | 469187 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.145 | 114841 | 5 |
0.150 | 104043 | 3 |
0.155 | 234472 | 5 |
0.160 | 572733 | 9 |
0.165 | 152123 | 4 |
Last trade - 10.46am 04/09/2024 (20 minute delay) ? |
Featured News
ALA (ASX) Chart |